Description
Bicalutamide is an oral nonsteroidal antiandrogen cytostatic, which is devoid of other endocrine activity. It connects to androgen receptors without activating gene expression and thus inhibits the androgen stimulus. It is used to treat prostate cancer, and hirsutism.
Indications
– For treatment of advanced cancer of the prostate in combination with analogue of LHRH or operative castration.
The drug product is indicated for treatment of adult men.
Subject to medical prescription
Pharmaceutical form: 50 mg x 28 film-coated tablets
NHIF code: LF 114 ICD: C61
